Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion type Assertion NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_head.
- NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion description "[Loss of Afadin was correlated with loss of FHIT expression, suggesting fragility of FRA6E and FRA3B in a certain proportion of breast tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_provenance.
- NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion evidence source_evidence_literature NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_provenance.
- NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion SIO_000772 16819513 NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_provenance.
- NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion wasDerivedFrom befree-20140225 NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_provenance.
- NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_assertion wasGeneratedBy ECO_0000203 NP277711.RA5-4EwlbmcOT2FDe_Hs2L-suZ8x-vq6-JwP0QDymyE2Q130_provenance.